Resumen de negocios
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Specialty Pharmaceuticals
100,0
%
| 27 | 100,0 % | 29 | 100,0 % | +6,12 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
60,0
%
| 16 | 60,0 % | 17 | 60,0 % | +6,12 % |
United States
40,0
%
| 11 | 40,0 % | 11 | 40,0 % | +6,12 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 26/03/19 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 15/08/22 |
James Bowen
IRC | Investor Relations Contact | - | - |
Emilio Presti
SAM | Sales & Marketing | - | - |
Diane Gajewczyk
PRN | Corporate Officer/Principal | - | 05/06/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 08/08/16 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 21/06/23 |
Craig Mull
CEO | Chief Executive Officer | - | 26/03/19 |
Hubert Walinski
BRD | Director/Board Member | - | 21/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 24 112 843 | 13 271 046 ( 55,04 %) | 0 | 55,04 % |
Información de la empresa
Cipher Pharmaceuticals, Inc.
5750 Explorer Drive Suite 404
L4W 0A9, Mississauga
+905-602-5840
http://www.cipherpharma.comVentas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+50,70 % | 795 mil M | |
+41,96 % | 627 mil M | |
-7,15 % | 350 mil M | |
+18,77 % | 328 mil M | |
+8,79 % | 294 mil M | |
+18,02 % | 245 mil M | |
+1,27 % | 222 mil M | |
+11,95 % | 215 mil M | |
+3,68 % | 160 mil M |